ciglitazone has been researched along with Infections, Helicobacter in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konturek, PC | 1 |
| Kania, J | 1 |
| Kukharsky, V | 1 |
| Raithel, M | 1 |
| Ocker, M | 1 |
| Rembiasz, K | 1 |
| Hahn, EG | 1 |
| Konturek, SJ | 1 |
1 other study available for ciglitazone and Infections, Helicobacter
| Article | Year |
|---|---|
Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori-infection.
Topics: Adult; Cell Line, Tumor; Cell Proliferation; Cytokines; Female; Gastric Mucosa; Helicobacter Infecti | 2004 |